Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Abobotulinumtoxina by Ipsen for Migraine: Likelihood of Approval
Abobotulinumtoxina is under clinical development by Ipsen and currently in Phase III for Migraine. According to GlobalData, Phase III drugs...